We are currently investigating whether IFN-γ plays a role in the function of human Tregs as this may help us to understand whether it is possible to target IFN-γ–induced JAK-STAT1-AKT signaling pathways to prolong allograft survival, prevent graft-versus-host disease or treat autoimmune diseases. This evidence concerns the gene AKT1 and autoimmune disease.